Concept
Cancer Challenges
Cancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute / The Road Ahead
"But the same data that celebrates progress also reveals how far we still have to go. Pancreatic cancer survival remains stagnant at 13%, meaning an estimated 185 Americans diagnosed today face essentially unchanged odds. Uterine corpus cancer mortality continues its 26-year climb."
Related Ideas
- Immunotherapy ReachCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · What the Report Means for Immunotherapy
- Cancer ProgressCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · Progress Is Real, But Uneven
- Melanoma ProgressCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · Immunotherapy Is Helping Rewrite Survival Curves
- Geographic GapsCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · Progress Is Real, But Uneven
- Health InequitiesCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · Progress Is Real, But Uneven
- Early DetectionCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · What the Report Means for Immunotherapy
- Young AdultsCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · Progress Is Real, But Uneven
- Cancer BurdenCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · Cancer Burden: By the Numbers